ArticleAmerican journal of translational research2025
Use of blood glucose level for predicting the degree of coronary artery disease and cardiovascular adverse events in diabetic patients with acute coronary syndrome.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the predictive value of blood glucose level in patients with type 2 diabetes mellitus (T2DM) and acute coronary syndrome (ACS) concerning the degree of coronary artery disease and major adverse cardiovascular events (MACE).
methodA retrospective study was conducted on 104 T2DM patients with ACS who visited West China Hospital, Sichuan University, from August 2020 to March 2024. Based on the Gensini score, patients were categorized into mild (0-30 points), moderate (31-59 points), and severe (≥60 points) groups. Additionally, patients were divided into MACE and non-MACE groups based on the occurrence of MACE. General information, blood glucose levels, and coronary angiography results were collected, along with six-month follow-up data. The predictive value of blood glucose levels for the severity of coronary artery disease and cardiovascular adverse events was analyzed using receiver operating characteristic (ROC) curves.
resultsThere were significant differences in the levels of glycosylated serum protein (GSP), insulin-like growth factor-1 (IGF-1), and the triglyceride-glucose (TyG) index among patients with varying degrees of coronary artery disease (
conclusionBlood glucose levels in T2DM patients with ACS have predictive value for both the severity of coronary artery disease and the occurrence of MACE. Measurement of GSP, IGF-1, and TyG is clinically significant for assessing prognosis and developing treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.